Horizon Therapeutics USA, Inc
Registered Principal Details
Business Or Interest:
Pharmaceutical industry and medicines for rare, autoimmune and severe inflammatory diseases.
Lobbying Interests:
All matters relating to the pharmaceutical industry and medicines for rare, autoimmune and severe inflammatory diseases
CEO Name:
Tim Walbert
Director
Pharmaceutical industry and medicines for rare, autoimmune and severe inflammatory diseases.
Lobbying Interests:
All matters relating to the pharmaceutical industry and medicines for rare, autoimmune and severe inflammatory diseases
CEO Name:
Tim Walbert
Director
Contact
JI
Julie Idelkope
1 Horizon Way
Deerfield, IL 60015
(612) 805-5493
jidelkope@horizontherapeutics.com
https://www.horizontherapeutics.com/
1 Horizon Way
Deerfield, IL 60015
(612) 805-5493
jidelkope@horizontherapeutics.com
https://www.horizontherapeutics.com/
Authorized Lobbyists
| Lobbyist Name | Exclusive Duties | Authorized On | Withdrawn On |
|---|
Lobbying Interests
Legislative Bills/Resolutions
Assembly Bill 744
Toggle details
Assembly Bill 744
Relating to: rare disease advisory council. (FE)
Bill Text and History
1/4/2022
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: rare disease advisory council. (FE)
Bill Text and History
For
Notification Date1/4/2022
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 689
Toggle details
Senate Bill 689
Relating to: rare disease advisory council. (FE)
Bill Text and History
1/4/2022
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: rare disease advisory council. (FE)
Bill Text and History
For
Notification Date1/4/2022
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Topics Not Yet Assigned A Bill Or Rule Number
Development, drafting or introduction of a proposal relating to the creation of a Rare Disease Advisory Council.
Development, drafting or introduction of a proposal relating to
Development, drafting or introduction of a proposal relating to the creation of a Rare Disease Advisory Council.
Development, drafting or introduction of a proposal relating to the creation of a Rare Disease Advisory Council.
Action Intended To Affect
Both Legislative matter and rule
Notification Date
10/21/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Both Legislative matter and rule
Notification Date
10/21/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Total Lobbying Effort
| 2021 July - December |
2022 January - June |
2022 July - December |
Total | |
|---|---|---|---|---|
| Total Lobbying Expenditures | 2021 July - December $15,000.00 |
2022 January - June $18,000.00 |
2022 July - December $18,000.00 |
Total $51,000.00 |
| Total Hours Communicating | 2021 July - December 0.00 |
2022 January - June 3.00 |
2022 July - December 0.00 |
Total 3.00 |
| Total Hours Other | 2021 July - December 3.00 |
2022 January - June 11.50 |
2022 July - December 0.00 |
Total 14.50 |
Percent Allocation of Lobbying Effort
Legislative Bills/Resolutions
Relating to: rare disease advisory council. (FE)
| 2021 January - June |
2021 July - December |
2022 January - June |
2022 July - December |
Total |
|---|---|---|---|---|
| 2021 January - June |
2021 July - December |
2022 January - June 20% |
2022 July - December |
Total 17% |
Relating to: rare disease advisory council. (FE)
| 2021 January - June |
2021 July - December |
2022 January - June |
2022 July - December |
Total |
|---|---|---|---|---|
| 2021 January - June |
2021 July - December |
2022 January - June 70% |
2022 July - December |
Total 57% |
Budget Bill Subjects
No budget bill subjects found.
Administrative Rulemaking Proceedings
No administrative rulemaking proceedings found.
Topics Not Yet Assigned A Bill Or Rule Number
Development, drafting or introduction of a proposal relating to the creation of a Rare Disease Advisory Council.
| 2021 January - June |
2021 July - December |
2022 January - June |
2022 July - December |
Total |
|---|---|---|---|---|
| 2021 January - June |
2021 July - December 100% |
2022 January - June 10% |
2022 July - December |
Total 25% |
Minor Efforts
No minor efforts found.
Other Matters
No other matters found.